Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination
Abstract The safety profile of COVID-19 vaccines is well-established, yet the widespread immunization campaign has led to an increase in reported cases of Immune-Mediated and Rheumatic Diseases (IMDRs). This study aimed to assess the reporting of Adverse Events Following Immunization (AEFIs) related...
Saved in:
| Main Authors: | Federica Fraenza, Cecilia Cagnotta, Mario Gaio, Liberata Sportiello, Cristina Scavone, Annalisa Capuano, Ugo Trama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-98313-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
by: E. L. Nasonov
Published: (2024-03-01) -
Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity
by: E. L. Nasonov, et al.
Published: (2020-09-01) -
Rheumatic heart valve disease: navigating the challenges of an overlooked autoimmune disorder
by: Adrien Lupieri, et al.
Published: (2025-03-01) -
Rituximab for rheumatic diseases in children: Results of a retrospective study of the safety of therapy
by: M. I. Kaleda, et al.
Published: (2021-05-01) -
THE MAIN MARKERS OF AUTOIMMUNE RHEUMATIC DISEASES AND THEIR INTERPRETATION
by: A. S. Burlakova, et al.
Published: (2016-10-01)